CREB1 and Alzheimer disease: Given the evidence for direct dysregulation of CREB by oAβ and reciprocal regulation of amyloidogenesis by CREB [27, 28, 51], an agent that elevates pCREB and biomarkers of synaptic function in the AD brain may have a reciprocal and beneficial effect on production and/or clearance of Aβ.